Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III).

Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III).
复制标题

DOI:
10.1176/appi.ajp.2021.20081202
复制
发表时间:
2022-01
期刊:
The American journal of psychiatry
影响因子:
--
通讯作者:
Hasin DS
Hasin DS
中科院分区:
其他
文献类型:
--
作者:
Browne KC;Stohl M;Bohnert KM;Saxon AJ;Fink DS;Olfson M;Cerda M;Sherman S;Gradus JL;Martins SS;Hasin DS

文献摘要

参考文献

被引文献

相似文献

估计美国退伍军人中过去12个月和一生的大麻使用和大麻使用障碍的患病率,描述非医用大麻使用和大麻使用障碍的人口统计学,物质使用障碍和精神障碍相关性,并探索有和没有医用大麻法律的退伍军人中大麻使用和大麻使用障碍患病率的差异。参与者是2012-2013年全国酒精和相关疾病流行病学调查-III(NESARC-III)中的3,119名受访者,他们被确定为美国退伍军人。计算加权患病率。Logistic回归测试了非医用大麻使用和大麻使用障碍与人口统计学和临床相关性的关系,并检查了各州合法化状况是否存在差异。任何过去12个月的大麻使用和大麻使用障碍的患病率分别为7.3%和1.8%。终生患病率分别为32.5%和5.7%。过去12个月和一生中,非医用大麻使用者的大麻使用障碍患病率估计为24.4%和17.4%。非医用大麻使用和使用障碍的社会人口学相关因素包括年龄较小,男性,未婚,收入较低,以及居住在有医用大麻法律的州。非医用大麻使用和使用障碍与大多数精神和物质使用障碍检查。在退伍军人中,非医用大麻使用和使用障碍的几率在弱势亚组中增加,包括低收入或精神疾病的人以及有医用大麻法律的州的参与者。研究结果强调了临床关注的必要性(例如,在日益合法化的背景下,对退伍军人进行筛查、评估)和持续监测。
To estimate the prevalence of past 12-month and lifetime cannabis use and cannabis use disorder among US veterans, describe demographic, substance use disorder, and psychiatric disorder correlates of non-medical cannabis use and cannabis use disorder, and explore differences in cannabis use and cannabis use disorder prevalence among veterans in states with and without medical marijuana laws. Participants were 3,119 respondents in the 2012–2013 National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III) who identified as US veterans. Weighted prevalences were calculated. Logistic regressions tested associations of non-medical cannabis use and cannabis use disorder with demographic and clinical correlates and examined whether prevalence differed by state legalization status. The prevalence of any past 12-month cannabis use and cannabis use disorder was 7.3% and 1.8%, respectively. Lifetime prevalences were 32.5% and 5.7%, respectively. Past 12-month and lifetime cannabis use disorder prevalence estimates among non-medical cannabis users were 24.4% and 17.4%. Sociodemographic correlates of non-medical cannabis use and use disorder included younger age, male gender, being unmarried, lower income, and residing in a state with medical marijuana laws. Non-medical cannabis use and use disorder were associated with most psychiatric and substance use disorders examined. Among veterans, the odds of non-medical cannabis use and use disorder were increased among vulnerable subgroups, including those with lower income or psychiatric disorders and among participants in states with medical marijuana laws. Findings highlight the need for clinical attention (e.g., screening, assessment) and ongoing monitoring among veterans in the context of increasing legalization.
酒精,大麻和其他药物使用:PTSD治疗中的参与和结果。
DOI: 10.1037/adb0000355
发表时间: 2018-05
影响因子: 3.4
作者:
Bedard-Gilligan, Michele;Garcia, Natalia;Zoellner, Lori A;Feeny, Norah C
通讯作者: Feeny, Norah C
DOI: 10.1016/j.addbeh.2017.08.010
发表时间: 2018-01-01
影响因子: 4.4
作者:
Davis, Alan K.;Lin, Lewei A.;Bohnert, Kipling M.
通讯作者: Bohnert, Kipling M.
DOI: 10.1176/appi.ajp.2015.15070907
发表时间: 2016-06-01
影响因子: 17.7
作者:
Hasin, Deborah S.;Kerridge, Bradley T.;Grant, Bridget F.
通讯作者: Grant, Bridget F.
DOI: 10.1001/jamapsychiatry.2015.0584
发表时间: 2015-08
期刊: JAMA psychiatry
影响因子: 25.8
作者:
Grant BF;Goldstein RB;Saha TD;Chou SP;Jung J;Zhang H;Pickering RP;Ruan WJ;Smith SM;Huang B;Hasin DS
通讯作者: Hasin DS